시장보고서
상품코드
1389609

세계 뇌 임플란트 시장 규모 및 예측 - 지역별 점유율, 동향, 성장 기회 분석 : 치료별, 용도별, 최종 사용자별, 지역별

Brain Implants Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Application, End User, and Geography

발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 205 Pages | 배송안내 : 즉시배송

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

뇌 임플란트 시장 규모는 2022년 72억 500만 달러에서 2030년에는 176억 4,700만 달러로 성장할 것으로 예측되며, 2022년부터 2030년 CAGR은 11.8%를 나타낼 것으로 추정됩니다.

뇌 임플란트 시장의 성장은 노년 인구 증가와 척수 손상 증가와 관련된 신경 장애의 급증으로 인한 것입니다.

기술의 발전으로 보다 작고 컴팩트한 뇌 임플란트가 개발되어 비침습적이거나 낮은 침습적인 수술에 적합합니다. 향상된 전극 설계, 고급 프로그래밍 알고리즘, 3D 프린팅, 브레인 컴퓨터 인터페이스(BCI), 운동 뉴런 인공 기관, 자기 충전식 임플란트, 메모리 칩, 소형화 등은 뇌 임플란트 시장의 최근 동향 일부이며 치료 효과를 향상시킬 가능성이 높습니다. 이러한 혁신은 환자에게 맞춤형, 적응성 및 기타 장기적인 이점을 제공합니다. 보다 작고 유연한 임플란트 개발 외에도 무선 통신 및 전력 공급 시스템의 발전으로 뇌 임플란트의 기능과 사용성이 향상될 수 있습니다. 침습성을 줄이고 사용자 경험을 개선함으로써 이러한 진보는 뇌 임플란트의 잠재적 적용 범위를 확대하고 보다 광범위한 환자 집단을 끌어들일 수 있습니다. 또한, 이러한 진보는 장기적인 임플란트가 필요한 환자에게도 유용합니다. 왜냐하면 소형 장치는 합병증의 위험을 낮추고 설치 및 제거가 쉬워지기 때문입니다.

인공지능(AI)과 머신러닝 알고리즘의 통합은 맞춤형 치료 및 실시간 적응 자극을 가능하게 함으로써 뇌 임플란트의 성능을 더욱 최적화할 수 있습니다. 인공지능이있는 신경 임플란트는 특히 알츠하이머 병으로 고통받는 환자의 삶의 질을 향상시킬 수 있습니다. 최근의 조사에 따르면 AI를 탑재한 브레인 머신 인터페이스는 알츠하이머의 진행을 효과적으로 식별 및 추적하여 조기 진단과 조기 개입으로 이어지는 것을 보여주고 있습니다. BCI 기술의 혁신은 심각한 장애를 가진 사람들에게 커뮤니케이션과 통제의 새로운 방법을 제공해 왔습니다. BCI는 폐쇄 증후군과 척수 손상을 가진 사람이 자신의 생각을 사용하여 주변과 상호 작용할 수 있습니다. 이 임플란트는 신경 신호를 해독하고 의지와 컴퓨터 인터페이스와 같은 외부 장비에 대한 명령으로 변환 할 수 있습니다.

Medtronic, Neuropace, St. Jude Medical과 같은 기업은 뇌 활동을 적극적으로 모니터링하는 시스템을 개발하고 있습니다. 일부 모니터링 시스템은 로봇 보조기구와 같은 다른 보조 장치와 함께 사용되어 신경 장애를 앓고있는 환자가 손실 된 운동 기능을 회복하는 데 도움이 됩니다. Emotiv과 NeuroSky와 같은 기업들은 장비 제어를 개선하기 위한 BCI의 발전에 주력하고 있습니다. 2023년 5월, 뇌 임플란트 회사인 Neurallink는 미국 FDA의 승인을 받아 인간을 대상으로 하는 뇌 임플란트의 첫 임상시험을 시작했습니다. 이 회사는 인공지능을 통해 인간의 두뇌를 컴퓨터 인터페이스에 통합하기 위해 노력하는 임플란트를 개발하기 위해 노력하고 있습니다. 마찬가지로, 2023년 2월, Precision Neuroscience는 마비 환자 및 기타 운동 제한이 있는 환자를 위한 획기적인 의료 기술을 도입할 계획에 착수했습니다. Precision의 뇌 임플란트 장치는 인간의 머리카락의 너비의 약 1/5이라는 초박막으로 스카치 테이프와 비슷한 접착력을 가지고 있습니다. 이 회사는 이 장비의 기능을 단계적으로 배포할 계획을 가지고 있습니다.

최종 사용자 기반 통찰력

뇌 임플란트 시장은 최종 사용자를 기반으로 병원과 전문 클리닉/신경학 센터로 구분됩니다. 병원 부문은 2022년에 큰 시장 점유율을 차지하고 2022-2030년에는 더 높은 CAGR을 기록할 것으로 예상됩니다. 의료는 복잡하지만 전문적인 과학 장비를 사용하여 의료 서비스를 제공하는 복잡한 조직입니다. 병원에서는 현대 의학 문제를 해결할 수 있도록 훈련된 전문가 팀을 고용하고 있습니다. 건강의 회복과 유지라는 공통 목표로 인해 이러한 모든 것이 협력하고 있습니다. 전문적인 건강 관리 시설로서, 병원은 뇌 임플란트의 개입이 필요한 다양한 신경 상태의 진단, 치료 및 관리를위한 중요한 설정을 갖추고 있습니다. 병원은 뇌 임플란트의 적절한 후보자의 평가와 선택을 포함하여 수술 전과 수술 후 치료를 제공합니다. 또한 지속적인 모니터링과 프로그래밍을 통해 임플란트가 제대로 작동하도록 후속 방문을 계획하고 결국 임플란트 수술을 받는 환자의 결과를 최적화합니다. 병원은 신경과 의사, 신경 외과 의사, 간호사 및 기타 의료 전문가로 구성된 학제 간 팀을 보유하고 뇌 임플란트를받는 환자에게 전문적인 치료를 제공하기 위해 협력하는 전문 지식 센터 로 역할을합니다.

병원은 또한 지식을 깊게 하고, 기술을 향상시키고, 뇌 임플란트 장치의 응용을 확대하기 위한 조사나 임상시험을 실시하는데 있어서 중요한 역할을 담당하고 있습니다. 헬스케어는 교육·연수 센터로서의 역할도 담당하고 있으며, 전문적인 연수 프로그램과 지속적인 의학 교육을 통해 의료 종사자가 뇌 임플란트 분야의 전문 지식을 높일 수 있는 기회를 제공합니다.

유럽은 이 시장에서 두 번째로 주요 지역입니다. 이 지역에서 독일은 2022년 시장에서 가장 큰 점유율을 차지하고 있습니다. Charite-Universitatsmedizin Berlin에서 2022년에 발표된 연구 “Deep brain stimulation for Parkinson's disease:new algorithm for the adjustment of stimulation settings developed”에 따르면, 파킨슨병(PD)은 알츠하이머병에 이어 두 번째로 많은 신경퇴행성 질환 입니다. 독일에서는 40만명이 이환하고 있어 인구동태의 고령화에 의해 증가 경향에 있습니다. 젊은 층을 포함한 많은 사람들이 신경 퇴행성 질환으로 고통받고 있습니다. DZNE(독일신경 퇴행성 질환센터)에 따르면 국내에서는 200만명 이상이 치매나 PD에 걸려 있다고 합니다. 뇌 임플란트는 PD의 잠재적 치료법으로 부상했습니다. 뇌심부자극요법(DBS)이라고도 불리는 이 임플란트는 뇌의 특정 부위에 수술적으로 전극을 설치하는 것입니다.

독일 정부의 통계에 따르면 2020년에는 19,356명이 알츠하이머병에 의한 입원 치료를 필요로 합니다. 알츠하이머의 진단에 의한 입원과 사망 증가는 독일의 고령화에 크게 의존하고 있습니다. 19,356건 중 11,188건은 80세 이상의 노인이며, 65세 이하에서는 1,026건밖에 기록되지 않았습니다. 뇌 임플란트에는 뇌 심부 자극 장치 및 미주 신경 자극 장치와 같은 의료기기가 포함됩니다. 이 장비는 신경 질환을 앓고있는 환자의 뇌와 뇌의 기능을 모니터링하는 데 도움이 됩니다. 따라서 위의 요인이 유럽에서 뇌 임플란트 시장의 성장을 뒷받침할 것으로 예상됩니다.

독일 정부 통계, Parkinson's Foundation UK, Alzheimer's Disease Research Factsheet, World Health Organization(WHO) 등은 뇌 임플란트 시장 보고서 작성 시 참조한 1차 조사 및 2차 정보입니다.

목차

제1장 서론

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 뇌 임플란트 시장 상황

  • PEST 분석
    • 세계의 PEST 분석

제5장 뇌 임플란트 시장 - 주요 산업 역학

  • 시장 성장 촉진요인
    • 노년 인구 증가에 수반하는 신경 질환의 급증
    • 척수 손상 증가
  • 주요 시장 성장 억제요인
    • 뇌 임플란트 장치 및 치료와 관련된 높은 비용
  • 주요 시장 기회
    • 기업에 의한 전략적 이니셔티브
  • 주요 장래 동향
    • 소형화, 인공지능, 최신 브레인 머신 인터페이스 등 기술 진보
  • 영향 분석

제6장 뇌 임플란트 시장 : 세계 시장 분석

  • 뇌 임플란트 시장의 수익(2022-2030년)

제7장 뇌 임플란트 세계 시장 : 치료별 수익과 예측(-2030년)

  • 뇌 임플란트 시장의 수익 점유율(2022년 및 2030년), 치료별
  • 뇌심부 자극요법
  • 척수 자극
  • 미주 신경 자극
  • 침습적 및 비침습적 브레인 컴퓨터 인터페이스
  • 발작에 대한 반응성 신경 자극
  • 청각뇌간 임플란트
  • 안과 보조 및 임플란트

제8장 뇌 임플란트 세계 시장 : 용도별 수익과 예측(-2030년)

  • 뇌 임플란트 시장의 수익 점유율(2022년 및 2030년), 용도별
  • 만성 통증
  • 파킨슨병
  • 알츠하이머병
  • 간질
  • 본태성 진전
  • 우울증
  • 근긴장
  • 근위축성 측삭 경화증
  • 신경 섬유종증 2형

제9장 뇌 임플란트 세계 시장 : 최종 사용자별 수익과 예측(-2030년)

  • 뇌 임플란트 시장의 수익 점유율, 최종 사용자별(2022년 및 2030년)
  • 병원
  • 전문 클리닉 및 신경센터

제10장 뇌 임플란트 시장 - 지역별 분석

  • 북미
    • 멕시코
  • 유럽
    • 기타 유럽
  • 아시아태평양
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 기타 중동 및 아프리카
  • 중남미
    • 기타 중남미

제11장 뇌 임플란트 시장 - 업계 정세

  • 뇌 임플란트 시장의 성장 전략
  • 유기적 성장 전략
  • 무기적 성장 전략

제12장 기업 프로파일

  • Boston Scientific Corp
  • Medtronic Plc
  • Functional Neuromodulation Ltd
  • Fisher Wallace Laboratories Inc
  • Synchron Inc
  • Blackrock Microsystems Inc
  • Renishaw Plc
  • Abbott Laboratories
  • Neurospine LLC
  • CorTec GmbH
  • BrainGate
  • Aleva Neurotherapeutics SA
  • NeuroSky Inc
  • Neuralink Corp
  • NeuroPace Inc
  • ONWARD Medical NV
  • Paradromics Inc

제13장 부록

JHS 23.12.15

The brain implants market size is expected to grow from US$ 7.205 billion in 2022 to US$ 17.647 billion by 2030; it is estimated to record a CAGR of 11.8% during 2022 to 2030.

The brain implants market growth is attributed to the surging prevalence of neurological disorders with increasing geriatric population and rising number of spinal cord injuries.

Advancements in technology have led to the development of smaller, more compact brain implants, making them more suitable for noninvasive or minimally invasive surgical procedures. Improved electrode designs, advanced programming algorithms, 3D printing, brain-computer interfaces (BCI), motor neuron prostheses, self-charging implants, memory chips, and miniaturization are a few of the modern trends in the brain implants market, which are likely to improve the effectiveness of treatments. These innovations provide patients with greater customization, adaptability, and other long-term benefits. In addition to the development of smaller and more flexible implants, advancements in wireless communication and power delivery systems can enhance the functionality and usability of brain implants. By reducing the invasiveness and improving the user experience, these advancements can expand the potential applications of brain implants and attract a broader patient population. Furthermore, these advancements benefit patients who require long-term implants, as smaller devices can lower the risk of complications and allow for easier placement and removal.

The integration of artificial intelligence (AI) and machine learning algorithms can further optimize the performance of brain implants by enabling personalized therapies and real-time adaptive stimulation. AI-powered neural implants have the potential to improve patients' quality of life, particularly those suffering from Alzheimer's disease. Recent research indicates that AI-powered brain-machine interfaces can effectively identify and track the progression of Alzheimer's, leading to earlier diagnosis and intervention. Innovations in BCI technology have provided new ways for communication and control for individuals with severe disabilities. BCIs can enable individuals with locked-in syndrome or spinal cord injuries to interact with their surroundings using their thoughts. These implants can decode neural signals and translate them into commands for external devices, such as prosthetic limbs or computer interfaces.

Companies such as Medtronic, Neuropace, and St. Jude Medical are developing systems to actively monitor brain activity. Some monitoring systems are used in conjunction with other assistive devices, such as robotic aids, to help patients suffering from neurological disorders to regain lost motor function. Companies such as Emotiv and NeuroSky are focused on advancing BCIs for improved device control. In May 2023, Neuralink, a brain implant company, received US FDA approval to begin the first-in-human clinical study of its brain implants in human subjects. The company is working on developing implants that promise to incorporate human brains with computer interfaces via AI. Similarly, in February 2023, Precision Neuroscience began working on its plan to introduce its groundbreaking medical technology to benefit paralyzed patients or those with other forms of limited mobility. Precision's brain implant device is a super thin film, about one-fifth of the width of a human strand of hair, that has a related consistency to that of a scotch tape. The company has plans to roll out the functionality of this device in stages.

End User-Based Insights

Based on end user, the brain implants market is segmented into hospitals and specialized clinics/neurological centre. The hospitals segment held a larger market share in 2022 and is anticipated to register a higher CAGR during 2022-2030. Hospitals are complex organizations that provide healthcare services by using complicated but specialized scientific equipment. They employ teams of professionals trained to address the problems of modern medical sciences. They are all coordinated together for the common goal of restoring and maintaining good health. As specialized healthcare facilities, hospitals have key set-ups for the diagnosis, treatment, and management of various neurological conditions that may require brain implant interventions. Hospitals provide pre- and post-operative care, which includes the assessment and selection of suitable candidates for brain implants. They also provide continuous monitoring and programming, and schedule follow-up visits to ensure the proper functioning of these implants, eventually optimizing outcomes for patients undergoing implantation procedures. Hospitals serve as centers of expertise, housing multidisciplinary teams of neurologists, neurosurgeons, nurses, and other healthcare professionals, who collaborate to provide specialized care for patients receiving brain implants.

Hospitals also play a crucial role in conducting research and clinical trials to advance knowledge, improve technologies, and expand the applications of brain implant devices. They serve as educational and training centers, providing opportunities for healthcare professionals to enhance their expertise in brain implantation area through specialized training programs and continuous medical education.

Europe is the second leading region in the market. In the region, Germany held the largest share of the market in 2022. According to a study published at Charite-Universitatsmedizin Berlin, titled "Deep brain stimulation for Parkinson's disease: new algorithm for the adjustment of stimulation settings developed," published in 2022, Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's. ~400,000 people were affected by the disease in the country, and the numbers are increasing due to demographic aging. A growing number of people, including younger people, suffer from neurodegenerative diseases. As per DZNE, German Center for Neurodegenerative Diseases, over 2 million people have dementia or PD in the country. Brain implants have emerged as a potential treatment for PD. These implants, also known as deep brain stimulation (DBS), involve the surgical placement of electrodes in specific areas of the brain.

According to the German government's statistics, 19,356 people required hospital care as a result of Alzheimer's in 2020. The increase in hospitalizations and deaths with Alzheimer's diagnosis is highly dependent on the aging population in Germany. Out of 19,356 cases, 11,188 were people aged 80 and above; only 1,026 cases were recorded among individuals aged 65 or younger. Brain implants include medical devices such as deep brain stimulator and vagus nerve stimulator. These devices help monitor brain and brain functions in patients suffering from neurological diseases. Therefore, the above-mentioned factors are expected to boost brain implants market growth in Europe.

German government's statistics, Parkinson's Foundation UK, Alzheimer's Disease Research Factsheet, and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the brain implants market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the brain implants market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global brain implants market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Brain Implants Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Brain Implants Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
    • 5.1.2 Rising Number of Spinal Cord Injuries
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost Associated with Brain Implant Devices and Procedures
  • 5.3 Key Market Opportunities
    • 5.3.1 Strategic Initiatives by Companies
  • 5.4 Key Future Trends
    • 5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
  • 5.5 Impact Analysis:

6. Brain Implants Market - Global Market Analysis

  • 6.1 Brain Implants Market Revenue (US$ Mn), 2022 - 2030

7. Global Brain Implants Market - Revenue and Forecast to 2030 - by Treatment.

  • 7.1 Overview
  • 7.2 Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Deep Brain Stimulation
    • 7.3.1 Overview
    • 7.3.2 Deep Brain Stimulation: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Spinal Cord Stimulation
    • 7.4.1 Overview
    • 7.4.2 Spinal Cord Stimulation: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Vagus Nerve Stimulator
    • 7.5.1 Overview
    • 7.5.2 Vagus Nerve Stimulator: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Invasive and Non-Invasive Brain-Computer Interfaces
    • 7.6.1 Overview
    • 7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Responsive Neurostimulation for Seizures
    • 7.7.1 Overview
    • 7.7.2 Responsive Neurostimulation for Seizures: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Auditory Brainstem Implant
    • 7.8.1 Overview
    • 7.8.2 Auditory Brainstem Implant: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.8.3 Retrocochlear Hearing Impairment
      • 7.8.3.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
    • 7.8.4 Cochlear Hearing Impairment
      • 7.8.4.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Ophthalmic Aids/Implant
    • 7.9.1 Overview
    • 7.9.2 Ophthalmic Aids/Implant: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Brain Implants Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Chronic Pain
    • 8.3.1 Overview
    • 8.3.2 Chronic Pain: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Parkinson's disease
    • 8.4.1 Overview
    • 8.4.2 Parkinson's disease: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Alzheimer's disease
    • 8.5.1 Overview
    • 8.5.2 Alzheimer's disease: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Epilepsy
    • 8.6.1 Overview
    • 8.6.2 Epilepsy: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Essential Tremor
    • 8.7.1 Overview
    • 8.7.2 Essential Tremor: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Depression
    • 8.8.1 Overview
    • 8.8.2 Depression: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Dystonia
    • 8.9.1 Overview
    • 8.9.2 Dystonia: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Amyotrophic Lateral Sclerosis
    • 8.10.1 Overview
    • 8.10.2 Amyotrophic Lateral Sclerosis (ALS): Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Neurofibromatosis 2
    • 8.11.1 Overview
    • 8.11.2 Neurofibromatosis 2: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Brain Implants Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Specialized Clinics / Neurological Centers
    • 9.4.1 Overview
    • 9.4.2 Specialized Clinics / Neurological Centers: Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

10. Brain Implants Market - Geographical Analysis

  • 10.1 North America Brain Implants Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.3 North America: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
      • 10.1.3.1 North America: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
    • 10.1.4 North America: Brain Implants Market, by Application, 2020-2030 (US$ Million)
    • 10.1.5 North America: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.5.1 North America Brain Implants Market, by Country
      • 10.1.5.2 US
        • 10.1.5.2.1 US Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.5.2.2 US: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.5.2.2.1 US: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.5.2.3 US: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.4 US: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.5.3 Canada
        • 10.1.5.3.1 Canada Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.5.3.2 Canada: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.5.3.2.1 Canada: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.5.3.3 Canada: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.4 Canada: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.5.4 Mexico
        • 10.1.5.4.1 Mexico Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.5.4.2 Mexico: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.5.4.2.1 Mexico: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.5.4.3 Mexico: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.4.4 Mexico: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
  • 10.2 Europe Brain Implants Market, Revenue and Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.2.3 Europe: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
      • 10.2.3.1 Europe: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
    • 10.2.4 Europe: Brain Implants Market, by Application, 2020-2030 (US$ Million)
    • 10.2.5 Europe: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
    • 10.2.6 Europe Brain Implants Market, by Country
      • 10.2.6.1 UK
        • 10.2.6.1.1 UK Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.1.2 UK: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.2.6.1.2.1 UK: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.2.6.1.3 UK: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.4 UK: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.2.6.2 Germany
        • 10.2.6.2.1 Germany Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.2.2 Germany: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.2.6.2.2.1 Germany: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.2.6.2.3 Germany: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.4 Germany: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.2.6.3 France
        • 10.2.6.3.1 France Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.3.2 France: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.2.6.3.2.1 France: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.2.6.3.3 France: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.4 France: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.2.6.4 Italy
        • 10.2.6.4.1 Italy Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.4.2 Italy: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.2.6.4.2.1 Italy: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.2.6.4.3 Italy: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.4 Italy: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.2.6.5 Spain
        • 10.2.6.5.1 Spain Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.5.2 Spain: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.2.6.5.2.1 Spain: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.2.6.5.3 Spain: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.4 Spain: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.2.6.6 Rest of Europe
        • 10.2.6.6.1 Rest of Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.6.2 Rest of Europe: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.2.6.6.2.1 Rest of Europe: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific Brain Implants Market, Revenue and Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.3.3 Asia Pacific: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
      • 10.3.3.1 Asia Pacific: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
    • 10.3.4 Asia Pacific: Brain Implants Market, by Application, 2020-2030 (US$ Million)
    • 10.3.5 Asia Pacific: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
    • 10.3.6 Asia Pacific Brain Implants Market, by Country
      • 10.3.6.1 China
        • 10.3.6.1.1 China Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.1.2 China: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.3.6.1.2.1 China: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.3.6.1.3 China: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.4 China: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.3.6.2 Japan
        • 10.3.6.2.1 Japan Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.2.2 Japan: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.3.6.2.2.1 Japan: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.3.6.2.3 Japan: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.4 Japan: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.3.6.3 India
        • 10.3.6.3.1 India Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.3.2 India: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.3.6.3.2.1 India: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.3.6.3.3 India: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.4 India: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.3.6.4 Australia
        • 10.3.6.4.1 Australia Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.4.2 Australia: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.3.6.4.2.1 Australia: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.3.6.4.3 Australia: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.4 Australia: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.3.6.5 South Korea
        • 10.3.6.5.1 South Korea Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.5.2 South Korea: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.3.6.5.2.1 South Korea: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.3.6.5.3 South Korea: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific
        • 10.3.6.6.1 Rest of Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.6.2 Rest of Asia Pacific: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.3.6.6.2.1 Rest of Asia Pacific: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Brain Implants Market, Revenue and Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.4.3 Middle East & Africa: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
      • 10.4.3.1 Middle East & Africa: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Brain Implants Market, by Application, 2020-2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
    • 10.4.6 Middle East & Africa Brain Implants Market, by Country
      • 10.4.6.1 Saudi Arabia
        • 10.4.6.1.1 Saudi Arabia Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.1.2 Saudi Arabia: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.4.6.1.2.1 Saudi Arabia: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.4.6.1.3 Saudi Arabia: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.4.6.1.4 Saudi Arabia: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.4.6.2 UAE
        • 10.4.6.2.1 UAE Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.2.2 UAE: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.4.6.2.2.1 UAE: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.4.6.2.3 UAE: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.4.6.2.4 UAE: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.4.6.3 South Africa
        • 10.4.6.3.1 South Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.3.2 South Africa: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.4.6.3.2.1 South Africa: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.4.6.3.3 South Africa: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.4.6.3.4 South Africa: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa
        • 10.4.6.4.1 Rest of Middle East & Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.4.2 Rest of Middle East & Africa: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.4.6.4.2.1 Rest of Middle East & Africa: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
  • 10.5 South & Central America Brain Implants Market, Revenue and Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.5.3 South & Central America: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
      • 10.5.3.1 South & Central America: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
    • 10.5.4 South & Central America: Brain Implants Market, by Application, 2020-2030 (US$ Million)
    • 10.5.5 South & Central America: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
    • 10.5.6 South & Central America Brain Implants Market, by Country
      • 10.5.6.1 Brazil
        • 10.5.6.1.1 Brazil Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.1.2 Brazil: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.5.6.1.2.1 Brazil: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.5.6.1.3 Brazil: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.1.4 Brazil: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.5.6.2 Argentina
        • 10.5.6.2.1 Argentina Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.2.2 Argentina: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.5.6.2.2.1 Argentina: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.5.6.2.3 Argentina: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.4 Argentina: Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.5.6.3 Rest of South & Central America
        • 10.5.6.3.1 Rest of South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.3.2 Rest of South & Central America: Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.5.6.3.2.1 Rest of South & Central America: Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.5.6.3.3 Rest of South & Central America: Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Brain Implants Market, by End-User, 2020-2030 (US$ Million)

11. Brain Implants Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Brain Implants Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Boston Scientific Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Functional Neuromodulation Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 SWOT Analysis
    • 12.3.5 Key Developments
  • 12.4 Fisher Wallace Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Synchron Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 SWOT Analysis
    • 12.5.5 Key Developments
  • 12.6 Blackrock Microsystems Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 SWOT Analysis
    • 12.6.5 Key Developments
  • 12.7 Renishaw Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Abbott Laboratories
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Neurospine LLC
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 SWOT Analysis
    • 12.9.5 Key Developments
  • 12.10 CorTec GmbH
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 SWOT Analysis
    • 12.10.5 Key Developments
  • 12.11 BrainGate
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 SWOT Analysis
    • 12.11.5 Key Developments
  • 12.12 Aleva Neurotherapeutics SA
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 SWOT Analysis
    • 12.12.5 Key Developments
  • 12.13 NeuroSky Inc
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 SWOT Analysis
    • 12.13.5 Key Developments
  • 12.14 Neuralink Corp
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 SWOT Analysis
    • 12.14.5 Key Developments
  • 12.15 NeuroPace Inc
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 ONWARD Medical NV
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Paradromics Inc
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 SWOT Analysis
    • 12.17.5 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제